DownsideMAt the AGM someone asked what the greatest threat was, and the answer given wasn’t related to financing. GROW is a relatively low-cost model given that they’re beyond the development stage. The greatest threat they suggested was that management may not be able to keep up with pressure to scale. To me that only means that they would be in a position to be bought out by an entity with the resources and capabilities to scale to a level that meets demand. Not the worst problem to have, though it means they would have to have the means to negotiate that kind of deal to benefit of the shareholders. And it assumes that someone wiould want to spend their hard-earned resources on scaling this operation. But even if cannabis trials turn up a bust, or HC exemption is a no-go, we still have outdoor California agricultural trials coming up in the summer, and with that we are competing with NO other option for outdoor CO2 enhancement. That is big for me, and a reason I m investing. I While it sounds like a cliche, I do think we’re just getting started.